Corient Capital Partners, LLC Abiomed Inc Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Abiomed Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 5,298 shares of ABMD stock, worth $0. This represents 0.1% of its overall portfolio holdings.
Number of Shares
5,298
Previous 5,283
0.28%
Holding current value
$0
Previous $1.31 Million
0.31%
% of portfolio
0.1%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding ABMD
# of Institutions
12Shares Held
137KCall Options Held
0Put Options Held
0-
Eaton Vance Management Boston, MA127KShares$00.05% of portfolio
-
Advisor Partners LLC Walnut Creek, CA1.31KShares$00.02% of portfolio
-
Redpoint Investment Management Pty LTD1.11KShares$00.04% of portfolio
-
Bluestein R H & CO LLC Birmingham, MI1.03KShares$00.02% of portfolio
-
American Portfolios Advisors Holbrook, NY691Shares$00.01% of portfolio
About ABIOMED INC
- Ticker ABMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 45,460,900
- Description
- Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...